Interleukin-13 and tumour necrosis factor-α synergistically induce eotaxin production in human nasal fibroblasts

Clinical and Experimental Allergy

Volumn 30, Issue 3, 2000, Pages 348-355

  Terada, N ^a   Hamano, N ^a   Nomura, T ^a   Numata, T ^a   Hirai, K ^b   Nakajima, T ^b   Yamada, H ^b   Yoshie, O ^c   Ikeda Ito, T ^d   Konno, A ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Nissui Pharmaceutical Co Ltd   (Japan)

Author keywords

Chemokines; Eosinophils; Eotaxin; Fibroblasts; Interleukin 4; Interleukin 13; Nasal allergy

Indexed keywords

CHEMOKINE; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; NOSE MUCOSA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; GLYCOPROTEINS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MALE; MITES; NASAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, PERENNIAL; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034068783     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00750.x     Document Type: Article

References (33)

1. Bazan JF, Bacon KB, Hardiman G. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385:640-5.
2. Kitaura M, Nakajima T, Imai T et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996; 271:7725-30.
3. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996; 97:604-12.
4. Collins PD, Marleau S, Griffiths JD, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182:1169-74.
5. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996; 183:2349-54.
6. Garcia ZE, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 1996; 2:449-56.
7. Ponath PD, Qin S, Post TW et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996; 183:2437-48.
8. Uguccioni M, Loetscher P, Forssmann U et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 1996; 183:2379-84.
9. Hohki G, Terada N, Hamano N et al. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochem Biophys Res Commun 1997; 241:136-41.
10. Peled A, Gonzalo JA, Lloyd C, Gutierrez RJ. The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation. Blood 1998; 91:1909-16.
11. Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998; 91:2240-8.
12. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998; 160:60-8.
13. McKenzie A, De Malefyt RW, Briere F et al. Interleukin 13: a T cell derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci U S A 1993; 90:3735-9.
14. Cocks BG, de Waal Malefyt R, Galizzi JP, deVries JE. IL-13 induces proliferation and differentiation of human B. Int Immunol 1993; 5:657-63.
15. Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994; 79:135-43.
16. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan PS, Bennett B. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151:6370-81.
17. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune response. Nature 1993; 362:248-50.
18. Punnonen J, Anersa G, Cocks BG et al. Interleukin-13 induces IL-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1994; 90:3730-4.
19. Park LS, Friend D, Sassenfeld M, Urdal DL. Characterization of the human B cell stimulatory factor I receptor. J Exp Med 1987; 166:476-88.
20. Terada N, Maesako K, Hamano N et al. Eosinophil adhesion regulates RANTES production in nasal epithelial cells. J Immunol 1997; 158:5464-70.
21. Hansel T, de Vrias I, Iff T. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991; 145:105-10.
22. Nakajima T, Yamada H, Iikura M et al. Intercellular localization and release of eotaxin from normal eosinophils. FEBS Lett 1998; 434:226-30.
23. Chomczynski P, Sacci N. Sigle-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
24. Saiki RK, Gelfand DH, Stoffel S et al. Primer-detected enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487-91.
25. Sambook J, Fritsch E, Maniatis T. Analysis of genomic DNA by Southern hybridization. In: Sambook J, Fritsch F, Maniatis T, eds. Molecular Cloning. New York, NY: Cold Spring Harbor Laboratory Press 1989:9:31-62.
26. Ganzalo JA, Jia GQ, Aguirre V et al. Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 1996; 4:1-14.
27. Bernstein JM, Gorfien J, Noble B, Yankaskas JR. Nasal polyposis: Immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps). J Allergy Clin Immunol 1997; 99:165-75.
28. Lugli SM, Feng N, Heim MH et al. Tumor necrosis factor alpha enhances the expression of the interleukin (IL) -4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation. Biol Chem 1997; 272:5487-94.
29. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992; 176:1381-6.
30. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997; 99:1492-9.
31. Steffen M, Abboud M, Potter GK, Yung XP, Moore MAS. Presence of tumor necrosis factor α or a related factor in human basophil mast cells. Immunology 1989; 66:445-51.
32. Costa J, Matossian K, Resnick M et al. Human eosinophils can express the cytokines tumor necrosis factor-α and macropharge inflammatory protein-α. J Clin Invest 1993; 91:2673-84.
33. Finotto S, Ohno I, Marshall J et al. TNF-α production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994; 153:2278-89.